Chen Z, Xie F, Zhang H, Li D, Zhang S, Zhang M
Front Public Health. 2025; 13:1478627.
PMID: 39935878
PMC: 11811089.
DOI: 10.3389/fpubh.2025.1478627.
Hickey T, Mudunuri U, Hempel H, Kemp T, Roche N, Talsania K
Front Immunol. 2025; 15:1502458.
PMID: 39931577
PMC: 11808009.
DOI: 10.3389/fimmu.2024.1502458.
Chemaitelly H, Ayoub H, Coyle P, Tang P, Hasan M, Yassine H
Nature. 2025; .
PMID: 39910292
DOI: 10.1038/s41586-024-08511-9.
Mambelli F, de Araujo A, Farias J, de Andrade K, Ferreira L, Minoprio P
Pathogens. 2025; 14(1).
PMID: 39860984
PMC: 11768231.
DOI: 10.3390/pathogens14010023.
Lau C, Oh H, Aw T
Vaccines (Basel). 2025; 13(1).
PMID: 39852788
PMC: 11768752.
DOI: 10.3390/vaccines13010009.
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A....
Shinde V, Lombard Koen A, Hoosain Z, Archary M, Bhorat Q, Fairlie L
Hum Vaccin Immunother. 2024; 20(1):2425147.
PMID: 39666396
PMC: 11789733.
DOI: 10.1080/21645515.2024.2425147.
Factors Predicting COVID-19 Vaccine Effectiveness and Longevity of Humoral Immune Responses.
Berber E, Ross T
Vaccines (Basel). 2024; 12(11).
PMID: 39591186
PMC: 11598945.
DOI: 10.3390/vaccines12111284.
Enhancing Immune Responses against SARS-CoV-2 Variants in Aged Mice with INDUK: A Chimeric DNA Vaccine Encoding the Spike S1-TM Subunits.
Cui L, Wang J, Orlando F, Giacconi R, Malavolta M, Bartozzi B
ACS Omega. 2024; 9(32):34624-34635.
PMID: 39157118
PMC: 11325517.
DOI: 10.1021/acsomega.4c03285.
Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics.
Zhang J
Heliyon. 2024; 10(14):e34577.
PMID: 39149061
PMC: 11325674.
DOI: 10.1016/j.heliyon.2024.e34577.
Exposure proximal immune correlates analysis.
Huang Y, Follmann D
Biostatistics. 2024; 26(1).
PMID: 39142660
PMC: 11823265.
DOI: 10.1093/biostatistics/kxae031.
Safety and durability of mRNA-1273-induced SARS-CoV-2 immune responses in adolescents: results from the phase 2/3 TeenCOVE trial.
Figueroa A, Ali K, Berman G, Zhou H, Deng W, Xu W
EClinicalMedicine. 2024; 74:102720.
PMID: 39091673
PMC: 11293523.
DOI: 10.1016/j.eclinm.2024.102720.
Distinct SARS-CoV-2 populational immune backgrounds tolerate divergent RBD evolutionary preferences.
Ma W, Fu H, Jian F, Cao Y, Li M
Natl Sci Rev. 2024; 11(7):nwae196.
PMID: 39071101
PMC: 11275455.
DOI: 10.1093/nsr/nwae196.
Deisolation in the Healthcare Setting Following Recent COVID-19 Infection.
Baumgart S, McLachlan A, Kenny H, McKew G, Maddocks S, Chen S
Viruses. 2024; 16(7).
PMID: 39066294
PMC: 11281359.
DOI: 10.3390/v16071131.
SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study.
Karlowicz K, Lewandowski K, Tulewicz-Marti E, Maciejewska K, Tworek A, Stepien-Wrochna B
Prz Gastroenterol. 2024; 19(2):198-205.
PMID: 38939061
PMC: 11200064.
DOI: 10.5114/pg.2023.130126.
Durability of immune responses to SARS-CoV-2 infection and vaccination.
Suthar M
Semin Immunol. 2024; 73:101884.
PMID: 38861769
PMC: 11490408.
DOI: 10.1016/j.smim.2024.101884.
Associations between obesity, a composite risk score for probable long COVID, and sleep problems in SARS-CoV-2 vaccinated individuals.
Xue P, Merikanto I, Delale E, Bjelajac A, Yordanova J, Chan R
Int J Obes (Lond). 2024; 48(9):1300-1306.
PMID: 38849462
PMC: 11347373.
DOI: 10.1038/s41366-024-01556-w.
Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination.
Bullock Jr J, Hickey T, Kemp T, Metz J, Loftus S, Haynesworth K
Vaccines (Basel). 2024; 12(5).
PMID: 38793767
PMC: 11125776.
DOI: 10.3390/vaccines12050516.
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity.
Wolz O, Vahrenhorst D, Quintini G, Lemberg C, Koch S, Kays S
Vaccines (Basel). 2024; 12(4).
PMID: 38675770
PMC: 11053638.
DOI: 10.3390/vaccines12040388.
How has research on the effectiveness and safety of COVID-19 vaccination been evaluated: a scope review with emphasis on CoronaVac.
Alzate-Angel J, Aviles-Vergara P, Arango-Londono D, Concha-Eastman A, Garces-Hurtado A, Lopez-Carvajal L
Front Public Health. 2024; 12:1321327.
PMID: 38660359
PMC: 11040685.
DOI: 10.3389/fpubh.2024.1321327.
Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
Fang F, Clemens J, Zhang Z, Brewer T
PLoS One. 2024; 19(4):e0301830.
PMID: 38656933
PMC: 11042718.
DOI: 10.1371/journal.pone.0301830.
